Fighting antibiotic resistance—strategies and (pre) clinical developments to find new antibacterials

S Walesch, J Birkelbach, G Jézéquel, FPJ Haeckl… - EMBO …, 2023 - embopress.org
Antibacterial resistance is one of the greatest threats to human health. The development of
new therapeutics against bacterial pathogens has slowed drastically since the approvals of …

Novel antimicrobial agents for gram-negative pathogens

M Karvouniaris, MP Almyroudi, MH Abdul-Aziz, S Blot… - Antibiotics, 2023 - mdpi.com
Gram-negative bacterial resistance to antimicrobials has had an exponential increase at a
global level during the last decades and represent an everyday challenge, especially for the …

Antibacterial agents active against Gram negative bacilli in phase I, II, or III clinical trials

DL Paterson - Expert Opinion on Investigational Drugs, 2024 - Taylor & Francis
Introduction Antimicrobial resistance is a major threat to modern healthcare, and it is often
regarded that the antibiotic pipeline is 'dry.'Areas covered Antimicrobial agents active …

Pharmacokinetics of benapenem for injection in subjects with mild to moderate renal impairment

H Yang, M Zhang, Y Chen, H Ren, H Zhang… - European Journal of …, 2022 - Springer
Objective This study evaluated the pharmacokinetic (PK) characteristics of benapenem in
subjects with mild to moderate renal impairment to provide a reference for benapenem …

Model-informed drug development of new cefoperazone sodium and sulbactam sodium combination (3: 1): Pharmacokinetic/pharmacodynamic analysis and …

XW Ji, X Zhu, Y Li, F Xue, IHS Kuan, QF He… - Frontiers in …, 2022 - frontiersin.org
Objective: Cefoperazone/sulbactam is a commonly used antibiotic combination against the
extended-spectrum beta-lactamases (ESBLs)-producing bacteria. The objective of this study …

[HTML][HTML] An Update on the Clinical Pipelines of New Antibacterial Drugs Developed in China

X Yang, C Li, X Wang, Z Zheng, P Sun, C Xu, L Chen… - Engineering, 2024 - Elsevier
Antibacterial resistance is a global health threat that requires further concrete action on the
part of all countries. In this context, one of the biggest concerns is whether enough new …

Combate à resistência aos antibióticos: novas moléculas/estratégias em fase clínica de desenvolvimento

PMA Nunes - 2023 - comum.rcaap.pt
Introdução: A resistência antimicrobiana é a capacidade de um microrganismo impedir que
um agente antimicrobiano funcione contra ele, impondo sérias limitações no tratamento de …

Antibioterapia das Infeções por Klebsiella pneumoniae

TB Valente - 2023 - sapientia.ualg.pt
As doenças infeciosas de etiologia bacteriana foram sempre um grave problema para a
sociedade, não só pela sua fácil e rápida propagação, como pela elevada mortalidade e …

38 Benapenem and Sulopenem

G Kanna, AP Kulkarni - Contemporary Topics in Critical Care …, 2022 - books.google.com
Penicillins, cephalosporins, carbapenems, and mono bactams are all βlactam antibiotics
and have a similar βlactam ring (Fig. 1) and mechanism of action (ie, inhibition of the …